Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Goodman

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Clinical and biochemical aspects of glutaric acidemia type IIS I Goodman, J P Loehr, F E Frerman
Pediatric Research|March 1, 1990
Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypesJ P Loehr, S I Goodman, F E Frerman
The Journal of Pediatrics|November 4, 2000
Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1K B Bjugstad, S I Goodman, C R Freed
Biochemistry|November 14, 2001
Binding, hydration, and decarboxylation of the reaction intermediate glutaconyl-coenzyme A by human glutaryl-CoA dehydrogenaseJ B Westover, S I Goodman, F E Frerman
Lancet (London, England)|November 30, 1974
Letter: Beta-galactosidase deficiency in young adultsD A Wenger, S I Goodman, G G Myers
Science (New York, N.Y.)|September 20, 1974
Type 2 hyperprolinemia: absence of delta1-pyrroline-5-carboxylic acid dehydrogenase activityD L Valle, J M Phang, S I Goodman
Progress in Clinical and Biological Research|January 1, 1992
Human cDNA encoding ETF dehydrogenase (ETF:ubiquinone oxido-reductase), and mutations in glutaric acidemia type IIS I Goodman, K F Bemelen, F E Frerman
Molecular Genetics and Metabolism|August 13, 1999
Assignment of electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) to human chromosome 4q33 by fluorescence in situ hybridization and somatic cell hybridizationE B Spector, W K Seltzer, S I Goodman
Progress in Clinical and Biological Research|January 1, 1992
Pork and human cDNAs encoding glutaryl-CoA dehydrogenaseS I Goodman, L E Kratz, F E Frerman
Journal of Inherited Metabolic Disease|January 1, 1989
Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementationW R Treem, C A Stanley, S I Goodman
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1990
Clinical and biochemical aspects of glutaric acidemia type IIS I Goodman, J P Loehr, F E Frerman
Pediatric Research|March 1, 1990
Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypesJ P Loehr, S I Goodman, F E Frerman
The Journal of Pediatrics|November 4, 2000
Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1K B Bjugstad, S I Goodman, C R Freed
Biochemistry|November 14, 2001
Binding, hydration, and decarboxylation of the reaction intermediate glutaconyl-coenzyme A by human glutaryl-CoA dehydrogenaseJ B Westover, S I Goodman, F E Frerman
Lancet (London, England)|November 30, 1974
Letter: Beta-galactosidase deficiency in young adultsD A Wenger, S I Goodman, G G Myers
Science (New York, N.Y.)|September 20, 1974
Type 2 hyperprolinemia: absence of delta1-pyrroline-5-carboxylic acid dehydrogenase activityD L Valle, J M Phang, S I Goodman
Progress in Clinical and Biological Research|January 1, 1992
Human cDNA encoding ETF dehydrogenase (ETF:ubiquinone oxido-reductase), and mutations in glutaric acidemia type IIS I Goodman, K F Bemelen, F E Frerman
Molecular Genetics and Metabolism|August 13, 1999
Assignment of electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) to human chromosome 4q33 by fluorescence in situ hybridization and somatic cell hybridizationE B Spector, W K Seltzer, S I Goodman
Progress in Clinical and Biological Research|January 1, 1992
Pork and human cDNAs encoding glutaryl-CoA dehydrogenaseS I Goodman, L E Kratz, F E Frerman
Journal of Inherited Metabolic Disease|January 1, 1989
Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementationW R Treem, C A Stanley, S I Goodman
Pageof 13